NPP Perftoran

NPP Perftoran is a specialized Russian biopharmaceutical company based in Pushchino, renowned for developing the world's first clinically approved perfluorocarbon-based blood substitute, Perftoran. Commonly referred to as "Blue Blood" for its unique appearance, the company's core technology is a submicron emulsion of perfluorodecalin and perfluoromethylcyclohexylpiperidine. This product acts as a gas-transporting agent, facilitating oxygen and carbon dioxide exchange in the microcirculation, which is particularly vital when natural red blood cells cannot reach tissues. The company focuses on applications in emergency medicine, surgery, and transplantology, providing solutions for hemorrhagic shock, severe blood loss, and organ preservation. While commercially available in Russia and the CIS, the technology is also being positioned for global markets under various rebranding efforts.